» Articles » PMID: 23069268

Restoration of Intracortical and Thalamocortical Circuits After Transplantation of Bone Marrow Mesenchymal Stem Cells into the Ischemic Brain of Mice

Overview
Journal Cell Transplant
Date 2012 Oct 17
PMID 23069268
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Transplantation of bone marrow mesenchymal stem cells (BMSCs) provides a promising regenerative medicine for stroke. Whether BMSC therapy could repair ischemia-damaged neuronal circuits and recover electrophysiological activity has largely been unknown. To address this issue, BMSCs were implanted into the ischemic barrel cortex of adult mice 1 and 7 days after focal barrel cortex stroke. Two days after the first transplantation (3 days after stroke), the infarct volume determined by TTC staining was significantly smaller in BMSC-treated compared to vehicle-treated stroke mice. The behavioral corner test showed better long-term recovery of sensorimotor function in BMSC-treated mice. Six weeks poststroke, thalamocortical slices were prepared and neuronal circuit activity in the peri-infarct region of the barrel cortex was determined by extracellular recordings of evoked field potentials. In BMSC-transplanted brain slices, the ischemia-disrupted intracortical activity from layer 4 to layer 2/3 was noticeably recovered, and the thalamocortical circuit connection was also partially restored. In contrast, much less and slower recovery was seen in control animals of barrel cortex stroke. Immunohistochemical staining disclosed that the density of neurons, axons, and blood vessels in the peri-infarct region was significantly higher in BMSC-treated mice, accompanied with enhanced local blood flow recovery. Western blotting showed that BMSC treatment increased the expression of stromal cell-derived factor-1 (SDF-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in the peri-infarct region. Moreover, the expression of the axonal growth associated protein-43 (GAP-43) was markedly increased, whereas the axonal growth inhibiting proteins ROCK II and NG2 were suppressed in the BMSC-treated brains. BMSC transplantation also promoted directional migration and survival of doublecortin (DCX)-positive neuroblasts in the peri-infarct region. The present investigation thus provides novel evidence that BMSC transplantation has the potential to repair the ischemia-damaged neural networks and restore lost neuronal connections. The recovered circuit activity likely contributes to the improved sensorimotor function after focal ischemic stroke and BMSC transplantation.

Citing Articles

Mesenchymal stem cells therapy for chronic ischemic stroke-a systematic review.

Kurniawan M, Ramli Y, Putri N, Harris S, Rasyid A, Mesiano T Asian Biomed (Res Rev News). 2024; 18(5):194-203.

PMID: 39483715 PMC: 11524678. DOI: 10.2478/abm-2024-0027.


MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research.

Zhang X, Kuang Q, Xu J, Lin Q, Chi H, Yu D Biomolecules. 2024; 14(5).

PMID: 38785945 PMC: 11117494. DOI: 10.3390/biom14050538.


Priming and Combined Strategies for the Application of Mesenchymal Stem Cells in Ischemic Stroke: A Promising Approach.

Tian H, Tian F, Ma D, Xiao B, Ding Z, Zhai X Mol Neurobiol. 2024; 61(9):7127-7150.

PMID: 38366307 DOI: 10.1007/s12035-024-04012-y.


Left Barrel Cortical Neurons Activity following Transplantation of Stem Cells into Right Lesioned-Barrel Cortex in Rats.

Sabzalizadeh M, Afarinesh M, Derakhshani A, Sheibani V Cell J. 2024; 25(12):822-828.

PMID: 38192252 PMC: 10777320. DOI: 10.22074/cellj.2023.2007586.1373.


Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges.

Asgari Taei A, Khodabakhsh P, Nasoohi S, Farahmandfar M, Dargahi L Mol Neurobiol. 2022; 59(10):6281-6306.

PMID: 35922728 DOI: 10.1007/s12035-022-02967-4.